Biology 2013, 2(2), 702-718; doi:10.3390/biology2020702
Article

Use of Tetravalent Galabiose for Inhibition of Streptococcus Suis Serotype 2 Infection in a Mouse Model

1 Department of Medicinal Chemistry and Chemical Biology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands 2 Department of Microbiology and Infection Control (MI), Statens Serum Institut, Copenhagen, Denmark 3 Department of Biosciences, Division of Biochemistry and Biotechnology, University of Helsinki, P.O.B. 56, Helsinki FI-00014, Finland 4 Department of Medical Biochemistry and Genetics, University of Turku, Kiinamyllynkatu 10, Turku FI-20520, Finland
* Author to whom correspondence should be addressed.
Received: 14 March 2013; in revised form: 26 March 2013 / Accepted: 28 March 2013 / Published: 8 April 2013
(This article belongs to the Special Issue Bacterial Adhesion)
PDF Full-text Download PDF Full-Text [851 KB, Updated Version, uploaded 15 April 2013 16:50 CEST]
The original version is still available [1043 KB, uploaded 8 April 2013 16:16 CEST]
Abstract: Streptococcus suis is an important swine pathogen associated with a variety of infections such as meningitis, arthritis and septicemia. The bacterium is zoonotic and has been found to cause meningitis especially in humans occupationally exposed to infected pigs. Since adhesion is a prerequisite for colonization and subsequent infection, anti-adhesion treatment seems a natural alternative to traditional treatment with antibiotics. In order to optimize the inhibitory potency a multivalency approach was taken in the inhibitor design. A synthetic tetravalent galabiose compound was chosen which had previously shown promising anti-adhesion effects with S. suis in vitro. The aim of this study was to evaluate the in vivo effects of the compound using an infection peritonitis mouse model. As such S. suis serotype 2 infection and treatment were tested in vivo and the effects were compared to the effect of treatment with penicillin.
Keywords: tetravalent galabiose; Streptococcus suis; adhesion inhibition; mouse model

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Pieters, R.J.; Slotved, H.-C.; Mortensen, H.M.; Arler, L.; Finne, J.; Haataja, S.; Joosten, J.A.F.; Branderhorst, H.M.; Krogfelt, K.A. Use of Tetravalent Galabiose for Inhibition of Streptococcus Suis Serotype 2 Infection in a Mouse Model. Biology 2013, 2, 702-718.

AMA Style

Pieters RJ, Slotved H-C, Mortensen HM, Arler L, Finne J, Haataja S, Joosten JAF, Branderhorst HM, Krogfelt KA. Use of Tetravalent Galabiose for Inhibition of Streptococcus Suis Serotype 2 Infection in a Mouse Model. Biology. 2013; 2(2):702-718.

Chicago/Turabian Style

Pieters, Roland J.; Slotved, Hans-Christian; Mortensen, Hanne M.; Arler, Lene; Finne, Jukka; Haataja, Sauli; Joosten, John A.F.; Branderhorst, Hilbert M.; Krogfelt, Karen A. 2013. "Use of Tetravalent Galabiose for Inhibition of Streptococcus Suis Serotype 2 Infection in a Mouse Model." Biology 2, no. 2: 702-718.

Biology EISSN 2079-7737 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert